1-3 of 3
Martha Blaney, PharmD
Close
Sort by
Journal Articles

Imetelstat Rapidly Induces and Maintains Substantial Hematologic and Molecular Responses in Patients with Essential Thrombocythemia (ET) Who Are Refractory or Intolerant to Prior Therapy: Preliminary Phase II Results

Gabriela M. Baerlocher, MD, Elisabeth Oppliger Leibundgut, PharmD, Christina Ayran, Martha Blaney, PharmD, Bart Burington, Ph.D, Dianne Morfeld, Olatoyosi Odenike, MD, Oliver Ottman, MD, Anita Reddy, PhD, Alexander Roeth, MD, Gary Spitzer, MD, Monic J. Stuart, MD, MPH, Srdan Verstovsek, MD, PhD, David S. Snyder, MD
Journal: Blood
Blood (2012) 120 (21): 179.
https://doi.org/10.1182/blood.V120.21.179.179
Published: 2012
Journal Articles

TROPICS 2: A Phase III, Open-Label, Single-Arm Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters.

Cameron Tebbi, MD, John Costanzi, MD, Robert J Shulman, MD, Luke Dreisbach, MD, Brian R Jacobs, MD, Martha Blaney, PharmD, Mark Ashby, PhD, Barbara S Gillespie, MD, Susan M Begelman, MD
Journal: Blood
Blood (2009) 114 (22): 1074.
https://doi.org/10.1182/blood.V114.22.1074.1074
Published: 2009
Journal Articles

TROPICS 1: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Tenecteplase for Restoration of Function in Central Venous Catheters.

Nashat Gabrail, MD, Eric Sandler, MD, Veena Charu, MD, Nick Anas, MD, Eduardo Lim, MD, Martha Blaney, PharmD, Mark Ashby, PhD, Barbara S Gillespie, MD, Susan M Begelman, MD
Journal: Blood
Blood (2009) 114 (22): 173.
https://doi.org/10.1182/blood.V114.22.173.173
Published: 2009